Recombinant human C1 esterase inhibitor
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Recombinant human C1 esterase inhibitor, covering 2012-08-31 to 2018-09-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects [Phase 1]